Chiranjeevi Cheekati

Title: Chiranjeevi Cheekati: Innovator in Pharmaceutical Chemistry

Introduction

Chiranjeevi Cheekati is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug synthesis. His work is characterized by a focus on creating high-purity compounds that are essential for pharmaceutical applications.

Latest Patents

Chiranjeevi holds a patent for a process titled "Process for preparation of 4-fluoro-α-[2-methyl-1-oxopropyl]-γ-oxo-N-β-diphenylbenzene butane amide." This patent describes a method for synthesizing a diketone intermediate of atorvastatin, which is crucial in the production of this widely used cholesterol-lowering medication. The process ensures that the diketone intermediate is free from impurities, maintaining a purity level of about 0.05% or less of certain by-products. This innovative approach involves maintaining specific temperature conditions during the Friedel-Crafts acylation and halogenation processes.

Career Highlights

Chiranjeevi Cheekati is currently associated with Vijayasri Organics Limited, where he applies his expertise in organic synthesis to advance pharmaceutical development. His work has not only contributed to the company's portfolio but has also enhanced the overall quality of pharmaceutical intermediates produced.

Collaborations

Chiranjeevi has collaborated with notable colleagues, including Venkateswara Rao Tadanki and Trimurthulu Singavarapu. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Chiranjeevi Cheekati's contributions to pharmaceutical chemistry through his innovative patent demonstrate his commitment to advancing drug synthesis processes. His work continues to impact the pharmaceutical industry positively, ensuring the availability of high-quality medications.